Showing 2421-2430 of 20884 results for "".
- Chronic Illness and Depression: Assessing Risk in Comorbid Conditionshttps://reachmd.com/news/chronic-illness-and-depression-assessing-risk-in-comorbid-conditions/2474603/In the quiet spaces between routine medical checkups and ongoing medication refills, a more insidious burden often lingers—one that doesn’t show up on blood tests or imaging scans. For patients managing multiple chronic illnesses, the weight isn’t just physiologica
- Feeding Immunity: How Maternal Nutrition Shapes Childhood Allergy Riskhttps://reachmd.com/news/maternal-diet-and-child-food-allergy-outcomes/2474616/The medical community is increasingly examining how maternal diet during pregnancy and breastfeeding affects the development of food allergies in children. This article explores the latest research, emphasizing the critical role of nutrition during these pivotal de
- Childhood Obesity and Its Role in Adult Weight Stigmahttps://reachmd.com/news/childhood-obesity-and-its-role-in-adult-weight-stigma/2474575/A growing body of research is illuminating the often-overlooked social legacy of early-onset obesity: enduring weight stigma that follows individuals well into adulthood.
- Bioinformatics Illuminate Biomarkers in Anaplastic Thyroid Cancerhttps://reachmd.com/news/anaplastic-thyroid-cancer-differential-gene-expression-as-potential-biomarkers/2474601/In addressing anaplastic thyroid cancer (ATC), advanced bioinformatic strategies are illuminating unique patterns of gene expression that hold potential as critical biomarkers, transforming diagnostic and therapeutic paradigms.
- HER3 and Cancer Progression: Investigating Mechanisms of Therapy Resistancehttps://reachmd.com/news/her3-and-cancer-progression-investigating-mechanisms-of-therapy-resistance/2474612/The rediscovery of HER3 as a crucial player in cancer progression has transformed our understanding of tumor biology. Previously eclipsed by other ErbB receptors, HER3 is recognized for its intricate signaling networks that spur therapy resistance and foster cell s
- Pentoxifylline and Its Limitations in Severe Alcohol-Associated Hepatitishttps://reachmd.com/news/pentoxifylline-and-its-limitations-in-severe-alcohol-associated-hepatitis/2474606/Robust clinical trials and real-world data consistently indicate that pentoxifylline fails to improve survival in patients with severe alcohol-associated hepatitis. This evidence necessitates reevaluating its use as a treatment to decre
- Integrating Pharmacotherapy and Surgical Intervention in Rheumatoid Arthritis Managementhttps://reachmd.com/news/high-tibial-osteotomy-and-joint-preservation-in-rheumatoid-arthritis/2474599/Rheumatoid arthritis (RA) treatment is undergoing a paradigm shift as innovative medications and refined surgical techniques converge to improve patient outcomes. A particularly promising advancement is the integrated use of high tibial osteotomy (HTO) alongside mod
- Diet and Sodium Reduction: Implications for Heart Disease Riskhttps://reachmd.com/news/diet-and-sodium-reduction-implications-for-heart-disease-risk/2474594/Compelling evidence affirms the profound influence of dietary practices on cardiovascular health. With sodium consumption consistently surpassing advised levels, healthcare professionals are pivotal in steering patients toward heart-beneficial dietary habits.
- Cell Death Modulation: Therapeutic Insights for Neurodegenerative Conditionshttps://reachmd.com/news/cell-death-modulation-therapeutic-insights-for-neurodegenerative-conditions/2474592/The dynamic field of neurology continues to redefine possibilities by targeting underlying mechanisms of neurodegenerative diseases. A pivotal discovery involves the small molecule WEHI-3773, which effectively disrupts the BAX-VDAC2 interaction, cr
- Reimagining Allergy Immunotherapy: Faster, More Accessible Desensitization Protocolshttps://reachmd.com/news/allergy-immunotherapy-accelerating-access-and-effectiveness/2474589/Allergy immunotherapy is undergoing a quiet revolution, offering new hope for the millions of Americans who suffer from allergic rhinitis. Traditionally limited by lengthy treatment timelines and logistical burdens, immunotherapy is now being reshaped by emerging a